Form 4 for ONC BeOne Medicines Ltd.
Accepted 2026-08-27 17:12:32 ET · period of report 2026-08-25 · accession 0001739452-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-27 17:12 | 2026-08-25 | ONC | Wu Xiaobin | Pres, COO | S - Sale | $380.00 | -280 | 0 | -100% | -$106.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2026-08-25 | S | D | 280 | $380.00 | 0 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F2) The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. |